DC

Desire Collen

LV Leuven Research & Development Vzw: 22 patents #1 of 19Top 6%
LV Life Sciences Research Partners Vzw: 7 patents #4 of 32Top 15%
UN Unknown: 4 patents #4,220 of 83,584Top 6%
DV D. Collen Research Foundation Vzw: 3 patents #1 of 8Top 15%
TN Thrombogenics Nv: 3 patents #3 of 15Top 20%
The General Hospital: 2 patents #806 of 3,021Top 30%
LR Ludwig Institute For Cancer Research: 1 patents #339 of 611Top 60%
SF SUNY Research Foundation: 1 patents #430 of 1,231Top 35%
KA Kabivitrum Ab: 1 patents #23 of 51Top 50%
KD K.U. Leuven Research & Development: 1 patents #54 of 174Top 35%
📍 Winksele, BE: #2 of 13 inventorsTop 20%
Overall (All Time): #86,890 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 1–25 of 38 patents

Patent #TitleCo-InventorsDate
9085617 Anti-angiogenic therapy Jean-Marie Stassen, Peter Carmeliet 2015-07-21
8758748 Anti-angiogenic therapy Jean-Marie Stassen, Peter Carmeliet 2014-06-24
7888322 Use of VEGF and homologues to treat neuron disorders Peter Carmeliet, Bert Oosthuyse 2011-02-15
7875704 Anti-PLGF antibody Jean-Marie Stassen, Peter Carmeliet 2011-01-25
7727971 Use of placental growth factor for treating ischemic muscle disease Peter Carmeliet 2010-06-01
7709450 Stimulation of vascularization with VEGF-B-186 Ulf Eriksson, Xuri Li, Peter Carmeliet 2010-05-04
7604952 Detection and determination of the stages of coronary artery disease Paul Holvoet 2009-10-20
7592314 Use of VEGF and homologues to treat neuron disorders Peter Carmeliet, Bert Oosthuyse 2009-09-22
7579159 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2009-08-25
7482004 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage Peter Carmeliet, Sandro De Falco, Ruvo Menotti 2009-01-27
7445775 Yeast expression vector and a method of making a recombinant protein by expression in a yeast cell Nubuo Nagai, Yves Rene LaRoche 2008-11-04
7390627 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2008-06-24
7378250 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2008-05-27
7357929 Placental growth factor as a target for the treatment of osteoporosis Peter Carmeliet, Roger Bouillon, Gertrudis Carmeliet 2008-04-15
7341992 Lectin-like domain of thrombomodulin and its therapeutic use Edward Conway 2008-03-11
7229776 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2007-06-12
7229775 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2007-06-12
7226908 Use of VEGF and homologues to treat neuron disorders Peter Carmeliet, Bert Oosthuyse 2007-06-05
7166469 Detection and determination of the stages of coronary artery disease Paul Holvoet 2007-01-23
7105168 Method of improving ischemic muscle function by administering placental growth factor Peter Carmeliet 2006-09-12
6946438 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke Nobuo Nagai 2005-09-20
6902733 Staphylokinase derivatives with polyethyleneglycol 2005-06-07
6727102 Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins Paul Holvoet 2004-04-27
6720309 Method of inducing vasodilation and treating pulmonary hypertension using adenoviral-mediated transfer of the nitric oxide synthase gene Stefan Janssens, Kenneth D. Bloch 2004-04-13
6398757 Gene therapeutic treatment of blood vessel associated disorders Olivier Henry Varenne, Stefan Janssens 2002-06-04